Cite

HARVARD Citation

    McAllister, P. et al. (n.d.). P.016 Reduction in migraine-associated burden over 24 weeks of treatment with eptinezumab in patients with chronic migraine. Canadian journal of neurological sciences. pp. S11-S12. [Online]. 
  
Back to record